Clinical Trial Update: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial is evaluating a cytomegalovirus vaccine in orthotopic liver transplant candidates and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Liver Transplantation

Drugs mentioned

• CMV vaccine (investigational) (cytomegalovirus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplant | Phase 2 | Status: RECRUITING